Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Incident Management System

Posted on By

SOP for Incident Management System

Standard Operating Procedure for Incident Management System in Ocular Dosage Form Manufacturing

1) Purpose

The purpose of this SOP is to establish a structured Incident Management System (IMS) to promptly detect, assess, report, investigate, and mitigate incidents occurring during the manufacturing of ocular dosage forms, including eye drops, ointments, gels, and inserts. This ensures that incidents are managed effectively to minimize impact on product quality, safety, and regulatory compliance.

2) Scope

This SOP applies to all personnel involved in the manufacturing process of ocular dosage forms, including operators, supervisors, quality assurance, and management. It covers incidents related to equipment malfunction, process deviations, environmental issues, and personnel safety concerns.

See also  SOP for Gel Preparation System

3) Responsibilities

The Incident Management Team (IMT) is responsible for implementing and overseeing the IMS. The Quality Assurance (QA) department leads incident investigations, while department heads and personnel are responsible for reporting incidents promptly and implementing corrective actions.

4) Procedure

4.1 Incident Detection and Reporting

  1. Immediately report any incident or deviation from normal operations to the designated supervisor or QA representative.
  2. Use the Incident Report Form to document incident details, including date, time, location, description, and initial assessment of impact.

4.2 Incident Assessment and Classification

  1. Convene the IMT to assess the severity and potential impact of the incident on product
quality, safety, and regulatory compliance.
  • Classify the incident based on predefined criteria (e.g., critical, major, minor) to determine the level of response required.
  • 4.3 Incident Investigation

    1. Assign a qualified investigator to conduct a thorough investigation into the root cause(s) of the incident.
    2. Gather evidence, interview relevant personnel, and review documentation to identify contributing factors.
    3. Document the investigation findings, including the root cause analysis and corrective actions recommended.

    4.4 Incident Mitigation and Corrective Actions

    1. Implement immediate corrective actions to mitigate the impact of the incident and prevent recurrence.
    2. Develop a Corrective and Preventive Action (CAPA) plan based on investigation findings to address underlying causes.
    3. Assign responsibilities and timelines for CAPA implementation and verification.

    4.5 Incident Resolution and Closure

    1. Monitor the effectiveness of implemented corrective actions through follow-up assessments and verification.
    2. Close the incident report once all corrective actions are successfully implemented and verified.
    3. Archive incident documentation, including investigation reports, CAPA records, and follow-up assessments.

    5) Abbreviations, if any

    SOP: Standard Operating Procedure
    IMS: Incident Management System
    IMT: Incident Management Team
    QA: Quality Assurance
    CAPA: Corrective and Preventive Action

    6) Documents, if any

    1. Incident Report Form
    2. Investigation Report
    3. Corrective and Preventive Action (CAPA) Plan
    4. Follow-up Assessment Records
    5. Training Records related to incident management

    7) Reference, if any

    Good Manufacturing Practices (GMP) guidelines
    International Conference on Harmonization (ICH) guidelines Q9 and Q10
    Company-specific quality policies and procedures

    8) SOP Version

    Version 1.0

    See also  SOP for Aseptic Filling Machine
    Ocular (Eye) Dosage Forms Tags:Aseptic processing, Bioavailability in ocular drugs, Blow-fill-seal technology, Cleanroom standards, Conjunctival inserts, Contact lenses drug delivery, Drug stability testing, Ethylene oxide sterilization, Eye drops SOP, Gamma sterilization, Heat sterilization, HEPA filtration, Intraocular implants, Intraocular injections, Microemulsions in ophthalmics, Mucoadhesive polymers, Multidose ophthalmic bottles, ocular dosage forms, Ocular drug delivery, Ointment preparation, Ophthalmic formulations, Ophthalmic gels, Ophthalmic suspensions, Ophthalmic viscosity, Preservative-free formulations, Solubility issues, SOP for Ocular Dosage Forms, Sterile filtration, Sterile solutions, Sterility testing, Terminal sterilization, Topical ocular drugs

    Post navigation

    Previous Post: SOP for Laboratory Oven
    Next Post: SOP for Magnetic Hotplate Stirrer

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version